| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |